Sygnus Biotech Logo
ULSONUS GEL
Rx Only
Ready for 24-48h Central Dispatch
In Stock

ULSONUS GEL Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download
Cream & OintmentPrescription Required (Schedule Drug)

ULSONUS GEL

5.0(1 review)
Verified Quality Batch
Active Drug Composition

Choline Salicylate B.P 8.7% + Hydrochloride I.P 2.0% + Chloride Solution I.P. 0.01%

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

ULSONUS GEL (Choline Salicylate B.P 8.7% , Hydrochloride I.P 2.0% , Chloride Solution I.P. 0.01%) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.

Dosage FormGel
Packaging Presentation10gm
B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Indicated for therapeutic management within specified clinical indications under qualified physician guidance.

Mechanism of Action (MOA)

The active pharmacological principles in ULSONUS GEL deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.

Dosage & Posology

As directed by the registered medical practitioner. Strictly adhere to full course duration.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store in a cool place below 25°C. Do not freeze. Replace cap tightly after use.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentCream & Ointment
Dosage FormGel
Packaging Type10gm
Regulatory ScheduleSchedule H
Country of OriginIndia
Quality StandardWHO-GMP & ISO 9001:2015
Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

ULSONUS GEL features Choline Salicylate B.P 8.7% + Hydrochloride I.P 2.0% + Chloride Solution I.P. 0.01% prepared to high pharmaceutical purity standards.

Therapeutic ClassificationCream & Ointment
Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Verified Practitioner & Distributor Feedback

Customer & Clinical Reviews

Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.

5.0

Based on 1 verified review

5
1 (100%)
4
0 (0%)
3
0 (0%)
2
0 (0%)
1
0 (0%)
Verified Feedback
29 Jul 2026

Regularly stocked across our distri for ULSONUS GEL

ULSONUS GEL has been regularly stocked across our district hospital formulary, supporting swift recovery and prompt restoration of standard patient routine. The protective barrier foil preserves stability and uniform product integrity over extended shelf life. Demonstrates genuine pharmaceutical excellence with reliable supply and steady commercial pull.

Dr. Naveen Goyal•Senior General Physician, Agra
Distributor Inquiries

Questions Regarding ULSONUS GEL

What is the therapeutic indication and composition of ULSONUS GEL?

ULSONUS GEL contains Choline Salicylate B.P 8.7% , Hydrochloride I.P 2.0% , Chloride Solution I.P. 0.01% indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.

What packaging presentations are available for ULSONUS GEL?

ULSONUS GEL is supplied in tamper-evident 15g / 30g Laminated Aluminum Barrier Tube, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for ULSONUS GEL?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for ULSONUS GEL along with promotional visual aids, product cards, and marketing support.

What is the regulatory schedule and minimum order quantity (MOQ)?

ULSONUS GEL is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.

Related Formulations in Cream & Ointment

View all Cream & Ointment →
Cream & Ointment
TRIPCEE

TRIPCEE

Clobetasol 0.05% w/w , Neomycin 0.1% w/w , Miconazole 2% w/w

Pack:20gm
Cream & Ointment
VIVO+ GEL

VIVO+ GEL

Diclofenac Sodium 1% w/v + Linseed Oil 3% w/w + Methyl Salicylate 10% w/w +Capsaicin 0.025% w/w Menthol 5% w/w + Benzyl Alcohol 1% w/w

Pack:30gm
Cream & Ointment
OXIDINE TOOTH PASTE

OXIDINE TOOTH PASTE

Pottasium Nitrate + Sodium Monofluorophosphate + Triclosan

Pack:50gm
Cream & Ointment
ACNEGO ADVANCE CREAM

ACNEGO ADVANCE CREAM

Hydroquinone 2% w/w + Tretinoin 0.025% w/w + Mometasone Furoate 0.1% w/w

Pack:15gm
Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of ULSONUS GEL

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.